Neurones (NRO) Q3 2025 earnings summary

Executive summary

• Achieved 5.1% organic growth in Q3 2025 despite a declining French market.

• Strong performance in Data & AI, digital projects, ITSM (Service Now), and Business Process Management.

Financial highlights

• Q3 2025 revenues reached €207.9 million, up 5.7% year-over-year; organic growth was 5.1%.

• Revenues for the first nine months totaled €632.2 million, a 5.5% increase year-over-year; organic growth was 4.7%.

• Operating margin for Q3 was 9.6% of revenues, higher than in the first half; nine-month operating margin was 8.4% (unaudited, after 0.9% bonus share expenses).

Outlook and guidance

• Targeting annual revenues above €850 million and operating profit of at least 8% for the full year, following Q3 improvement.